Returns
NAV and returns as at 20 Aug 2026
Lumpsum · point to point
1W
+0%
1M
+0.87%
3M
+6.45%
6M
+14.19%
YTD
+12.63%
1Y
+9.68%
2Y CAGR
+7.61%
3Y CAGR
+20.27%
5Y CAGR
+15.5%
10Y CAGR
+15.07%
SIP · XIRR on monthly instalments
6M SIP
+39.1%
1Y SIP
+20.59%
2Y SIP
+12.45%
3Y SIP
+15.65%
5Y SIP
+18.99%
10Y SIP
+19.11%
Full history SIP
+19.11%
Periods up to one year are absolute; longer periods are annualised (CAGR). SIP figures are the XIRR of a fixed monthly instalment over the same window. — means this scheme’s NAV history does not cover that period — across all 1648 schemes, 68% have a 3-year figure, 48.8% a 5-year one, and 32.7% a 10-year one.
Top holdings
as at 31 Jul 2026 · source: AMC monthly portfolio disclosure
SUN PHARMACEUTICAL INDUSTRIES LTDPharmaceuticals & Biotechnology
8.59%
DIVI LABORATORIES LTDPharmaceuticals & Biotechnology
6.36%
HEALTHCARE GLOBAL ENTERPRISES LTDHealthcare Services
5.85%
ABBOTT INDIA LTDPharmaceuticals & Biotechnology
5.63%
RAINBOW CHILDRENS MEDICARE LTDHealthcare Services
4.9%
GLAXOSMITHKLINE PHARMACEUTICALS LTDPharmaceuticals & Biotechnology
4.66%
CIPLA LTDPharmaceuticals & Biotechnology
4.53%
DR REDDYS LABORATORIES LTDPharmaceuticals & Biotechnology
4.25%
MAX HEALTHCARE INSTITUTE LTDHealthcare Services
4.07%
APOLLO HOSPITALS ENTERPRISE LTDHealthcare Services
3.9%
Top 10 52.74%Securities 37Securities total 99.13%Cash & equivalents 0.87%
The ten largest securities by weight, out of 37 disclosed. Weight is percent of net assets as filed. Cash-equivalent lines (TREPS, reverse repo, net receivables, margin) and derivative legs are counted in the chips above but not ranked among securities, because a short futures leg is filed as a negative weight and sorting it alongside a shareholding describes no portfolio. A portfolio is a point-in-time filing and changes every month.
Risk
Volatility · annualised · 3Y
14.58%
Volatility is the annualised standard deviation of daily NAV moves over the last three years; max drawdown is the deepest peak-to-trough fall in that same window. Where a scheme has less than three years of NAV, the window is what it actually has and is labelled as such — never as three years. Sharpe is as disclosed in the scheme key-ratio feed (as at 24 July 2026).
Beta and alpha are not shown. No benchmark series in the source.
Cost
Expense ratio0.97%
Category average1.73%
Exit load0.25%
52W high / low₹40.1562 / ₹32.8027
Expense ratio 0.97% vs a category average of 1.73% — 0.76 percentage points lower. Among Sectoral/ Thematic schemes disclosing an expense ratio it is 50th of 166, cheapest first.
Expense ratio and category average are as disclosed against this scheme in the source; 78.5% of schemes here carry one. The ratio is charged inside the NAV, so every return on this page is already net of it.
Scheme facts
SEBI sub-category
Sectoral/ Thematic
Plan / option
Direct Growth
Benchmark
BSE Health Care - TRI
Fund manager
Rajat Srivastava
Launched
04 Dec 2015
NAV history here
10.0y
ISIN
INF277K019A3
AMFI scheme code
135810
SEBI riskometer
Very High
Exit load
0.25%
Lock-in
None
Minimum lumpsum
₹5,000
Exit load, as disclosed: 0.25% on or before 30D
Not shown on this page, and why
Star rating — GFS is an AMFI-registered distributor (ARN-169480), not a SEBI-registered investment adviser. It does not rate schemes.
Scheme AUM — Scheme-level AUM is not in the source; only AMC-total AUM, which is a different number.
Minimum SIP — Not present in the source.
Beta and alpha — No benchmark series in the source.